Re: - ** High-Dose Ursodeoxycholic Acid Fails in PSC**

[Guest guest]

As you can see in the below quotation of the article the statement

related to restoring normal life expectancy was related to treatment

of PBC, not PSC. It was certainly a hope that the same effect would

be observed in PSC but it appears from this study the opposite was

the case.

" The rationale for using UDCA has come in part from the drug's

effectiveness in primary biliary cirrhosis. UDCA at a dose of 13 to

15 mg/kg/day slows the development of cirrhosis and varices and may

restore normal life expectancy in patients who respond to the agent,

said Dr. Lindor. "

in Seattle

>

> -----Original Message-----

> I'm ever the optimimist, at one point on this release it actually

says

> that urso can " restore normal life expectancy "

> Is this true? Are there documented cases of it combatting cirhossis

that

> well???

>

> Hi ,

> You're right, it did say that, but..... you have to read the next

> sentence too, it said " To confirm the benefits observed in small

> uncontrolled studies " they weren't able to confirm that conclusion

in

> the larger Dr. Lindor study.

>

> Sorry,

>

> Barb in Texas - Together in the Fight - Whatever it Takes!

> Son Ken (34) UC 91 PSC 99, LTX 6/21 & 6/30 2007 @ Baylor/Dallas

>